Terhorst B, Friedrichs R
Urologische Klinik, Akademisches Lehrkrankenhaus der Universität Heidelberg, Bad Mergentheim.
Urologe A. 1990 Mar;29(2):91-5.
One hundred thirty-three patients with prostatic carcinoma underwent bilateral pelvic lymphadenectomy and radical retropubic prostatectomy between 1975 and 1988. Patients who had a localized prostatic carcinoma (less than or equal to T2b N0 M0 or less than or equal to B 2) and a small number (n = 10) with limited T3 carcinoma were considered for surgical therapy on the basis of a digital prostatic examination. Histological examination revealed locally advanced prostatic carcinoma in 89 patients with capsular infiltration or perforation and seminal vesicle involvement. Microscopic lymph node metastases were noted in 14 cases. Some patients with capsular perforation and seminal vesicle involvement received adjuvant therapy (orchiectomy or radiation). All patients with lymph node metastases were treated by orchiectomy. One local failure occurred among 24 patients with capsular infiltration within 42 months of follow-up. No failure occurred in stage pT3 disease (capsular perforation) with adjuvant therapy (n = 12) and in stage pT3 disease (seminal vesicle involvement) with (n = 9) and without (n = 12) adjuvant therapy after mean follow-up periods of 35, 42 and 52 months, respectively. Distant metastases occurred in 2 patients with stage pT3 disease (capsular perforation) without adjuvant therapy (n = 18) within a mean follow-up of 51 months, and 1 of these patients died of prostatic cancer. Distant metastases occurred in 3 patients with pT2-pT3N1 disease within a mean follow-up of 54 months: 1 of these patients died of prostatic cancer. Local failure was noted in 1 patient in this group.(ABSTRACT TRUNCATED AT 250 WORDS)
1975年至1988年间,133例前列腺癌患者接受了双侧盆腔淋巴结清扫术和耻骨后根治性前列腺切除术。根据直肠指检,那些患有局限性前列腺癌(小于或等于T2b N0 M0或小于或等于B 2)以及少数(n = 10)T3期癌局限的患者被考虑进行手术治疗。组织学检查显示,89例患者存在局部进展性前列腺癌,伴有包膜浸润或穿孔以及精囊受累。14例患者发现有微小淋巴结转移。一些包膜穿孔和精囊受累的患者接受了辅助治疗(睾丸切除术或放疗)。所有有淋巴结转移的患者均接受了睾丸切除术。24例包膜浸润患者在随访42个月内发生1例局部复发。接受辅助治疗的pT3期疾病(包膜穿孔,n = 12)、接受辅助治疗(n = 9)和未接受辅助治疗(n = 12)的pT3期疾病(精囊受累)患者,分别在平均随访35、42和52个月后均未出现复发。未接受辅助治疗的18例pT3期疾病(包膜穿孔)患者中,有2例在平均随访51个月时发生远处转移,其中1例死于前列腺癌。pT2 - pT3N1期疾病患者中有3例在平均随访54个月时发生远处转移:其中1例死于前列腺癌。该组中有1例患者出现局部复发。(摘要截短于250字)